Analyst Ratings for Acceleron Pharma (XLRN) [Neutrals]

XLRN Rating Summary

XLRN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on XLRN
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $152.00 (+24.7%) * Over Last 12-Mos
Rating Score: 8.1 / 10   Percentile Rank: 84%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/23/2021 SVB Leerink Geoffrey Porges Downgrade Market Perform
(Outperform)
148.00
(N/A)
143.64
(121.92)
-15.12% Details
3/22/2021 Goldman Sachs Corinne Jenkins New Coverage Neutral
(N/A)
132.00
(N/A)
133.58
(121.92)
-8.73% Details
Like XLRN Ratings? Also take a look at BMY

XLRN Ratings News